The emerging antimicrobial resistance crisis during the COVID-19 surge in China.
作者信息
Wang Zhicheng, Yu Mengke, Lin Leesa
机构信息
China Development Research Foundation, Beijing 100009, China.
China Development Research Foundation, Beijing 100009, China.
出版信息
Lancet Microbe. 2023 May;4(5):e290-e291. doi: 10.1016/S2666-5247(23)00038-1. Epub 2023 Feb 10.
Abstract
摘要
相似文献
1
The emerging antimicrobial resistance crisis during the COVID-19 surge in China.中国新冠疫情激增期间出现的抗菌药物耐药性危机。
Lancet Microbe. 2023 May;4(5):e290-e291. doi: 10.1016/S2666-5247(23)00038-1. Epub 2023 Feb 10.
2
Shortage of appropriate diagnostics for antimicrobial resistance in Lebanese clinical settings: a crisis amplified by COVID-19 and economic collapse.黎巴嫩临床环境中抗微生物药物耐药性的适当诊断方法短缺：一场因新冠疫情和经济崩溃而加剧的危机。
J Glob Antimicrob Resist. 2021 Dec;27:72-74. doi: 10.1016/j.jgar.2021.08.008. Epub 2021 Sep 4.
3
Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?在新冠疫情期间，抗菌药物耐药性的差异是否加剧了？
Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.
4
In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?寻求新冠治疗策略：我们是否正在引发抗菌素耐药性？
Disaster Med Public Health Prep. 2022 Aug;16(4):1285-1286. doi: 10.1017/dmp.2020.492. Epub 2020 Dec 22.
5
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.低收入和中等收入国家（以孟加拉国为例）新冠疫情后抗菌药物耐药性威胁
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
6
Combating antimicrobial resistance during the COVID-19 pandemic.在新冠疫情期间对抗抗菌药物耐药性
Hong Kong Med J. 2021 Dec;27(6):396-398. doi: 10.12809/hkmj215124. Epub 2021 Nov 17.
7
Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?新冠疫情期间的非病毒感染与抗菌药物耐药性：未来会怎样？
Expert Rev Clin Pharmacol. 2022 Aug;15(8):907-909. doi: 10.1080/17512433.2022.2108403. Epub 2022 Aug 3.
8
Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!抗微生物药物耐药性与新冠疫情：大流行后时代的一项更大挑战！
J Formos Med Assoc. 2021 Jul;120(7):1537-1538. doi: 10.1016/j.jfma.2021.03.003. Epub 2021 Mar 14.
9
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan.新冠疫情对巴基斯坦抗菌药物耐药性不断升级的潜在影响。
J Infect. 2021 Sep;83(3):e12-e13. doi: 10.1016/j.jinf.2021.07.024. Epub 2021 Jul 28.
10
Antimicrobial resistance and the COVID-19 pandemic.抗菌药物耐药性与新冠疫情
Bull World Health Organ. 2022 May 1;100(5):295-295A. doi: 10.2471/BLT.21.287752.
引用本文的文献
1
Patterns of antibiotic resistance in urinary tract infections before and during the COVID-19 pandemic in Uganda and Tanzania.乌干达和坦桑尼亚在新冠疫情之前及期间尿路感染的抗生素耐药模式。
JAC Antimicrob Resist. 2025 Mar 14;7(2):dlaf038. doi: 10.1093/jacamr/dlaf038. eCollection 2025 Apr.
2
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance.超级细菌管理前沿：对抗抗菌药物耐药性的创新方法
Arch Microbiol. 2025 Feb 14;207(3):60. doi: 10.1007/s00203-025-04262-x.
3
Clinical burden of community-associated infections caused by multidrug-resistant Pseudomonas aeruginosa: a propensity-matched longitudinal cohort study in Southern China.多重耐药铜绿假单胞菌引起的社区获得性感染的临床负担：中国南方一项倾向匹配纵向队列研究
GMS Hyg Infect Control. 2024 Oct 23;19:Doc51. doi: 10.3205/dgkh000506. eCollection 2024.
4
High Prevalence of Respiratory Co-Infections and Risk Factors in COVID-19 Patients at Hospital Admission During an Epidemic Peak in China.中国疫情高峰期间新冠病毒肺炎患者入院时呼吸道合并感染的高流行率及危险因素
Infect Drug Resist. 2023 Oct 25;16:6781-6793. doi: 10.2147/IDR.S435143. eCollection 2023.
5
Resistance Transition of in SARS-CoV-2-Uninfected Hospitalized Patients in the Pandemic.大流行期间未感染新冠病毒的住院患者的耐药性转变
Infect Drug Resist. 2023 Oct 16;16:6717-6724. doi: 10.2147/IDR.S423167. eCollection 2023.
Zotero 插件